NETSTREIT Corp. NTST 深 沪
已收盘 02-06 16:00:00 美东时间
19.33
-0.220
-1.13%
华盛通- 最 高19.65
- 今 开19.58
- 成交量 98.07万股
- 最 低 19.20
- 昨 收 19.55
- 总市值 16.15亿
- 52周最高 19.65
- 市盈率 静 --
- 换手率 1.17%
- 52周最低 12.89
- 委 比 97.35%
- 总股本 8356.17万
- 历史最高 23.235
- 量 比 0.81
- 振 幅 2.30%
- 历史最低 11.605
- 每 手 1
- 风险率 1.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 高露洁棕榄、再生元制药、伊士曼化工、威瑞森、Ameris、丘奇＆德怀特等获多家大行上调目标价
今日重点评级关注：Benchmark：维持Charter Communications"买入"评级，目标价从425美元升至455美元；BTIG：维持LifeStance Health Gr"买入"评级，目标价从10美元升至11美元
02-03 09:06
Scotiabank Maintains Sector Outperform on Netstreit, Raises Price Target to $21
Scotiabank analyst Nicholas Yulico maintains Netstreit (NYSE:NTST) with a Sector Outperform and raises the price target from $20 to $21.
02-02 23:10
NETSTREIT Announces 2025 Dividend Tax Characterization Details
NETSTREIT ( ($NTST) ) has shared an update. On January 27, 2026, NETSTREIT Corp...
01-28 06:47
NETSTREIT gets BBB- issuer default rating from Fitch
NETSTREIT (NTST) on Tuesday was assigned a long-term issuer default rating ("IDR") of BBB-, the lowest investment-grade rating on Fitch Ratings' scale, with a stable outlook. The new IDR reflects the ...
2025-12-31 05:38
美股大行评级 | 德银首予Coinbase"买入"评级，目标价340美元；AERO获多家机构首予超配评级；大摩维持苹果"超配"评级，目标价升至315美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从9美元升至10美元；摩根大通：上调Recursion Pharmaceuticals评级至"超配"，目标价从10美元升至11美元
2025-12-18 10:54
Mizuho Maintains Outperform on Netstreit, Lowers Price Target to $19
Mizuho analyst Haendel St. Juste maintains Netstreit (NYSE:NTST) with a Outperform and lowers the price target from $20 to $19.
2025-12-17 20:11
NETSTREIT lifts low end of full-year AFFO guidance
NETSTREIT (NTST) is raising the low end of its full-year 2025 AFFO guidance to $1.30 to $1.31 per diluted share from $1.29 to $1.31 previously expected. Full-year net investment activity guidance of $...
2025-11-18 19:32
Netstreit Raises FY2025 FFO Guidance from $1.29-$1.31 to $1.30-$1.31 vs $1.24 Est
"Due to increased visibility across a number of fronts, including the timing of fourth quarter net investment activity, we are increasing the low end of our full year 2025 AFFO per share guidance range. With a low
2025-11-18 19:07
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
2025-11-18 15:28
Truist Securities Maintains Buy on Netstreit, Raises Price Target to $20
Truist Securities analyst Ki Bin Kim maintains Netstreit (NYSE:NTST) with a Buy and raises the price target from $19 to $20.
2025-11-17 21:29
